Stay updated with breaking news from Sucherita kukreti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Republic Media Network successfully organized the 1st edition of the IES 2021 adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
'We'd be bonded labour': Why Republic staffers refused to sign a new contract and quit newslaundry.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newslaundry.com Daily Mail and Mail on Sunday newspapers.
Text Size: A+ New Delhi: Prime time debates Tuesday were focused on the Covid-19 vaccines and their expected rollout on 13 January. While the two vaccines Covishield and Covaxin have received approval from the government, the latter vaccine has been the subject of much criticism. Developed by Bharat Biotech and the Indian Council of Medical Research, Covaxin has neither released efficacy data nor has it completed Phase 3 trials. On India Today, Shiv Aroor took issue with opposition parties criticising the vaccine. “There have been doctors and experts who have demanded more data, who have constructive criticism about vaccine approvals and have demanded more information to support reasons why these approvals have been given in this manner,” said Aroor. ....